1. Home
  2. EXEL vs OHI Comparison

EXEL vs OHI Comparison

Compare EXEL & OHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXEL
  • OHI
  • Stock Information
  • Founded
  • EXEL 1994
  • OHI N/A
  • Country
  • EXEL United States
  • OHI United States
  • Employees
  • EXEL N/A
  • OHI N/A
  • Industry
  • EXEL Biotechnology: Biological Products (No Diagnostic Substances)
  • OHI Real Estate Investment Trusts
  • Sector
  • EXEL Health Care
  • OHI Real Estate
  • Exchange
  • EXEL Nasdaq
  • OHI Nasdaq
  • Market Cap
  • EXEL 10.4B
  • OHI 12.3B
  • IPO Year
  • EXEL 2000
  • OHI N/A
  • Fundamental
  • Price
  • EXEL $38.94
  • OHI $39.87
  • Analyst Decision
  • EXEL Buy
  • OHI Hold
  • Analyst Count
  • EXEL 22
  • OHI 9
  • Target Price
  • EXEL $44.10
  • OHI $43.13
  • AVG Volume (30 Days)
  • EXEL 2.9M
  • OHI 1.5M
  • Earning Date
  • EXEL 11-04-2025
  • OHI 10-30-2025
  • Dividend Yield
  • EXEL N/A
  • OHI 6.72%
  • EPS Growth
  • EXEL 81.76
  • OHI 23.41
  • EPS
  • EXEL 2.08
  • OHI 1.61
  • Revenue
  • EXEL $2,230,005,000.00
  • OHI $1,114,637,000.00
  • Revenue This Year
  • EXEL $9.14
  • OHI $12.23
  • Revenue Next Year
  • EXEL $12.59
  • OHI $7.97
  • P/E Ratio
  • EXEL $18.75
  • OHI $24.69
  • Revenue Growth
  • EXEL 10.73
  • OHI 14.04
  • 52 Week Low
  • EXEL $31.18
  • OHI $35.04
  • 52 Week High
  • EXEL $49.62
  • OHI $44.42
  • Technical
  • Relative Strength Index (RSI)
  • EXEL 50.54
  • OHI 41.97
  • Support Level
  • EXEL $33.76
  • OHI $39.26
  • Resistance Level
  • EXEL $40.63
  • OHI $41.00
  • Average True Range (ATR)
  • EXEL 1.30
  • OHI 0.68
  • MACD
  • EXEL 0.17
  • OHI -0.04
  • Stochastic Oscillator
  • EXEL 75.47
  • OHI 27.35

About EXEL Exelixis Inc.

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

About OHI Omega Healthcare Investors Inc.

Omega Healthcare Investors Inc is a healthcare facility real estate investment trust that invests in the United States real estate markets. Omega's portfolio focuses on long-term healthcare facilities. Omega has one reportable segment consisting of investments in healthcare-related real estate properties located in the United States and the United Kingdom. Its core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs).

Share on Social Networks: